Solana HSV 1+2/VZV Assay_微生物检测_药物检测仪器_仪器设备库_商城

货号：	QD-015
保存条件：	详见官方网站
供应商：	钰博生物
保质期：	详见说明书
英文名：	Solana HSV 1+2/VZV Assay
数量：	大量

Solana HSV 1+2/VZV Assay

The Solana HSV 1+2/VZV Assay is a multiplex in vitro diagnostic test for the detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), and Varicella-zoster virus (VZV) nucleic acids isolated and purified from cutaneous or mucocutaneous swab specimens obtained from symptomatic patients.

The Solana HSV 1+2/VZV Assay consists of two major steps: (1) specimen preparation, and (2) amplification and detection of target sequence specific to HSV-1, HSV-2 and/or VZV using isothermal Helicase-Dependent Amplification (HDA) in the presence of target-specific fluorescence probe.

Using HDA technology the target sequences are amplified by HSV-1, HSV-2 and/or VZV specific primers and detected by HSV-1, HSV-2 and/or VZV specific fluorescence probes included in the Reaction Tube. A competitive process control (PRC) is included in the Process Tube to monitor sample processing, inhibitory substances in clinical samples, reagent failure or device failure. The PRC target is amplified by specific primers and detected by a PRC specific fluorescence probe.

Results are displayed on the touchscreen, can be saved to the instrument, printed, and are capable of being sent to the LIS and exported through one of Solana’s five USB ports. Solana HSV 1+2/VZV is also supported by the power of Virena^®.

Features & Benefits

Feature	Benefit
HDA technology	Rapid method of nucleic acid amplification that does not require thermal cycler
Lyophilized Master Mix reagent	Easy-to-use format, just add processed sample to rehydrate
Small, easy-to-use instrument	Eliminates the need for dedicated molecular space and costly capital equipment, allowing for testing in smaller labs
CLIA moderately complex	Requires minimal training
Refrigerated storage	No freezer needed, 2˚C to 8˚C storage
Long shelf life	Currently 12 months from date of manufacture
Room temperature at set up	No ice or cooling block required

Product Specifications

Sample type	Cutaneous or mucocutaneous lesion samples obtained from symptomatic patients suspected of active herpes simplex virus type 1, herpes simplex virus type 2 and/or varicella-zoster infection.
Time to results	Approximately 50 minutes
Reagent storage conditions	Process Buffer and Reaction Tubes; 2˚C to 8˚C
Control storage conditions	2˚C to 8˚C
Sample preparation storage conditions (cultured enriched broth)	Room temperature (up to 30 °C) for up to 48 hours, 2° to 8°C or –20°C for up to 7 days prior to processing.
Sensitivity	Cutaneous: HSV-1 100.0%, HSV-2 92.3%, VZV 100%; Mucocutaneous: HSV-1 100%, HSV-2 99.1%, VZV 100.0%; Non categorized HSV-1 100%, HSV-2 100%, VZV 100.0%
Specificity	Cutaneous: HSV-1 98.0%, HSV-2 94.4%, VZV 96.5%; Mucocutaneous: HSV-1 96.4%, HSV-2 97.2%, VZV 98.6%; Non categorized HSV-1 97.9%, HSV-2 96.6%, VZV 94.1%